Dr. Himisha Beltran, an assistant professor of medicine and of medicine in urology, will receive a $2 million, three-year Prostate Cancer Research Program Transformative Impact Award from the U.S. Department of Defense to elucidate the mechanisms by which N-Myc promotes neuroendocrine prostate cancer (NEPC) and develop new therapeutic agents to treat it. The award supports prostate cancer research that has the potential to transform and revolutionize the disease’s clinical management.
Dr. Rohan Ramakrishna, the Alvina and Willis Murphy Assistant Professor of Neurological Surgery and an assistant professor of neurological surgery, was in March appointed a fellow of the Weill Cornell Healthcare Leadership Fellows Program. The program seeks to identify and foster the development of Weill Cornell Medicine’s “leaders of tomorrow.”
Dr. Michael Stewart, chairman and a professor of otolaryngology, the E. Darracott Vaughan, Jr., M.D. Senior Associate Dean for Clinical Affairs, and a professor of healthcare policy and research, was named president of the American Board of Otolaryngology’s Board of Directors, serving a one-year term starting in April. The board aims to assure the public that its diplomats have met the professional standards of training and knowledge in head and neck surgery. Members of the Board of Directors are selected based on personal qualities, leadership potential, collegiality, medical specialty, performance in organization activities and geography, as well as other qualifications.
Dr. George S. Alexopoulos, the Stephen P. Tobin and Dr. Arnold M. Cooper Professor in Consultation Liaison Psychiatry and a professor of psychiatry and of psychiatry in integrative medicine, won the Legacies Award from Lifeforce in Later Years, a non-profit organization that offers programs aimed at confronting issues that face elderly people in need. The Legacies Award honors individuals who have had a profound effect on elder care. Dr. Alexopoulos will receive the award May 1 at Lifeforce in Later Years’ annual gala in New York.
Michael Crowley, a third-year doctoral student, won in January a Scholar-in-Training Award from the American Association for Cancer Research and AbbVie for his abstract titled “Targeting IRE1a-XBP1 Signaling in Lung Cancer.” The highly competitive awards are presented to applicants with high-quality abstracts in the field of cancer research. Crowley received his award at the association’s annual meeting April 1 in Washington, DC.